|

Imlunestrant Clinical Trials

3 actively recruiting trials across 2 locations

▼ -1 trial since September 2026

Also known as: Inluriyo, LY 3484356, LY-3484356, LY3484356, SERD LY3484356 +1 more

Pipeline

Phase 2: 2Phase 1/2: 1

Top Sponsors

  • Eli Lilly and Company2
  • Jonsson Comprehensive Cancer Center1

Indications

  • Breast Cancer3
  • Cancer3
  • Localized Human Epidermal Growth Factor Receptor (HER2)-Negative Breast Carcinoma1
  • Localized Estrogen Receptor-Positive Breast Carcinoma1
  • Solid Tumors, Adult1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.